BiohacksAI/Mechanism Hypothesis/Tirofiban Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in

Tirofiban Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in — Mechanism Gap Analysis

HYPOTHESIS_ENGINE_v1.0 · Corpus v20260227-01 · Deterministic graph-traversal

Known Targets

RATTUSHOMOSLC6A4ITGA2BITGAVITGB3

6 known targets mapped from PubChem bioassay data

Pathway Context

Hemostasis3 targets overlapping

L1CAM interactions3 targets overlapping

Extracellular matrix organization3 targets overlapping

Uncovered Pathway Targets

185 total

ABCC4ABL1ADRA2AADRA2BADRA2CALBANXA2APPARRB1ATP1B1+175 more…

Genes present in the top pathway union that Tirofiban Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in does not directly modulate.

Top Stack Candidates

Sorafenib

#1 gap-filler · 27 targets covered · evidence score 44.4

score 6,913.754

ABL1CDK5CSKFGRFYNIFNB1LCKLYNMAPK1MAPK14MAPK3MERTK+15

Dasatinib

#2 gap-filler · 21 targets covered · evidence score 45.0

score 5,225.702

ABL1CSKFGRFYNJAK2LCKLYNMAPK14RAF1SRCSYKTP53+9

556 more candidates · full stack optimisation locked

Enter your API token to unlock the complete analysis.

BiohacksAI maps biological mechanisms. It does not recommend compounds. Results generated by HYPOTHESIS_ENGINE_v1.0.